Jiangsu, China

Gang Qiao

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 9.5

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Gang Qiao: Innovator in Pharmaceutical Research

Introduction

Gang Qiao is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors that target specific biological processes. With a total of three patents to his name, Qiao's work is paving the way for advancements in the treatment of various diseases.

Latest Patents

Gang Qiao's latest patents include a histone acetyltransferase (HAT) inhibitor and a bromodomain inhibitor compound. The HAT inhibitor patent discloses a compound represented by a specific general formula, along with various forms such as pharmaceutically acceptable salts and stereoisomers. This invention aims to provide a method for treating HAT-related diseases or conditions. The bromodomain inhibitor patent similarly outlines a compound and its various acceptable forms, focusing on its pharmaceutical applications.

Career Highlights

Throughout his career, Gang Qiao has worked with esteemed institutions such as the Chinese Academy of Sciences and Suzhou Suplead Life Sciences Co., Ltd. His experience in these organizations has allowed him to refine his research skills and contribute to significant advancements in life sciences.

Collaborations

Gang Qiao has collaborated with notable colleagues, including Bing Zhou and Cheng Luo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.

Conclusion

Gang Qiao's innovative work in pharmaceutical research, particularly through his patents, showcases his commitment to advancing medical science. His contributions are vital in the ongoing quest for effective treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…